Appropriate selection of a device is of critical importance to achieve the best outcome. The following needs to be taken into account: etiology of heart failure and anticipated duration of support, ...

ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3™ heart pump ...

"This is a landmark event for children suffering from terminal heart failure." Charles D. Fraser, Jr., MD, Texas Children’s Hospital THE WOODLANDS, Tex., and BERLIN, Dec. 16, 2011—The Berlin Heart ...

Few options besides extracorporeal membrane oxygenation (ECMO) have been available for children with systolic heart failure awaiting transplantation. Now a new report by Charles Fraser, Jr and ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR ® Pediatric Ventricular Assist Device, a requirement of the Post ...

The Berlin Heart EXCOR® Pediatric VAD is a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure. The system is designed to support pediatric ...

Please provide your email address to receive an email when new articles are posted on . The first prospective FDA-regulated device trial using a pediatric ventricular assist device registry was ...

The field of pediatric mechanical circulatory support with ventricular assist devices has lagged significantly behind that of adult patients. However, there is increasing attention on the emerging ...

THE WOODLANDS, Texas--(BUSINESS WIRE)--Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR ® Pediatric Ventricular Assist Device, a requirement of the Post ...

THE WOODLANDS, Texas, Aug. 4, 2014 /PRNewswire/ --The Berlin Heart Group announced today that they have completed enrollment in their Post Approval Study, the only condition of the "Humanitarian ...